LEA MURPHY: Open Payments
NPI 1336818905 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 68 payments from 18 companies in 2025. Trend: 2023 $1,896 · 2024 $649 · 2025 $1,377
Food & beverage: $1,277Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $333 |
| Incyte Corporation | 15 | $231 |
| Janssen Biotech, Inc. | 5 | $221 |
| Amgen Inc. | 4 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $69 |
| UCB, Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $39 |
Products named: OPZELURA, TREMFYA, SKYRIZI, BOTOX, OTEZLA, DUPIXENT, Bimzelx, TALTZ.
Industry payments across NY — which companies pay providers there.
